1. Economic and Social Impact of OAB
Con J Kelleher 
European Urology Supplements 
Volume 1, Issue 4, Pages (July 2002)
DOI: /S (02)00043-X

2. Fig. 1
Prevalence of OAB reported in the NOBLE study [2]. OAB dry: four or more episodes of urgency in the preceding 4 weeks, and either frequency more than eight voids per day or the use of one or more coping behaviors to control bladder function. OAB wet: same criteria as OAB dry, plus three or more episodes of urinary incontinence in the past 4 weeks that could not be explained by stress symptoms.
European Urology Supplements 2002 1, 11-16DOI: ( /S (02)00043-X)

3. Fig. 2
The prevalence of common chronic conditions in the US (dagger refers to data from [2] and asterisk refers to data from [8]).
European Urology Supplements 2002 1, 11-16DOI: ( /S (02)00043-X)

4. Fig. 3
Model for the economic evaluation of OAB treatment. QALY: quality-adjusted life year.
European Urology Supplements 2002 1, 11-16DOI: ( /S (02)00043-X)

5. Fig. 4
Scores generated by the Short Form (SF) 36 questionnaire in the NOBLE program. OAB dry: four or more episodes of urgency in the preceding 4 weeks, and either frequency more than eight voids per day or the use of one or more coping behaviors to control bladder function. OAB wet: same criteria as OAB dry, plus three or more episodes of urinary incontinence in the past 4 weeks that could not be explained by stress symptoms.
European Urology Supplements 2002 1, 11-16DOI: ( /S (02)00043-X)

6. Fig. 5
Quality of life for patients with OAB, genuine stress incontinence (GSI) and normal urodynamics (UDS): cumulative mean scores for 392 women completing part II of the KHQ [20].
European Urology Supplements 2002 1, 11-16DOI: ( /S (02)00043-X)